Fungal keratitis: Mechanisms of infection and management strategies

• Published in: Survey of ophthalmology Vol. 67; no. 3; pp. 758 - 769
• Main Authors: Donovan, Christopher, Arenas, Eduardo, Ayyala, Ramesh S, Margo, Curtis E, Espana, Edgar M.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-05-2022
• Subjects: Antifungal Agents - therapeutic use; Confocal microscopy; Corneal Ulcer - drug therapy; Corneal Ulcer - therapy; Eye Infections, Fungal - drug therapy; Eye Infections, Fungal - therapy; Fungal; Humans; Keratitis; Keratitis - drug therapy; Keratitis - therapy; Keratolysis; Ulcer - drug therapy; Yeast; Keratolysis; Confocal microscopy; Yeast; Keratitis; Fungal
• ISSN: 0039-6257; 1879-3304
• DOI: 10.1016/j.survophthal.2021.08.002

Fungal corneal ulcers are an uncommon, yet challenging, cause of vision loss. In the United States, geographic location appears to dictate not only the incidence of fungal ulcers, but also the fungal genera most encountered. These patterns of infection can be linked to environmental factors and individual characteristics of fungal organisms. Successful management of fungal ulcers is dependent on an early diagnosis. New diagnostic modalities like confocal microscopy and polymerase chain reaction are being increasingly used to detect and identify infectious organisms. Several novel therapies, including crosslinking and light therapy, are currently being tested as alternatives to conventional antifungal medications. We explore the biology of Candida, Fusarium, and Aspergillus, the three most common genera of fungi causing corneal ulcers in the United States and discuss current treatment regimens for the management of fungal keratitis.